| Clinical data | |
|---|---|
| Trade names | Phenurone |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| ATC code | |
| Pharmacokinetic data | |
| Eliminationhalf-life | 22–25 hours |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.519 |
| Chemical and physical data | |
| Formula | C9H10N2O2 |
| Molar mass | 178.191 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Phenacemide (INN,BAN) (brand namePhenurone), also known asphenylacetylurea, is ananticonvulsant of theureide (acetylurea) class.[1] It is acongener and ring-openedanalogue ofphenytoin (ahydantoin),[2][3] and is structurally related to thebarbiturates and to otherhydantoins.[4] Phenacemide was introduced in 1949 for the treatment ofepilepsy, but was eventually withdrawn due totoxicity.[2][3]
{{cite book}}:|journal= ignored (help)Thisanticonvulsant-related article is astub. You can help Wikipedia byexpanding it. |